Slam Exploration Stock Price, News & Analysis
Company Description
Slam Exploration (OTC Link: SXLXF) is a publicly traded gold company in the Basic Materials sector. The company has a market capitalization of $7.5M.
SXLXF stock has gained 3.0% over the past year. Shares last traded at $0.0574.
This page provides a comprehensive overview of SXLXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Slam Exploration (SXLXF) stock last traded at $0.0574. Over the past 12 months, the stock has gained 3.0%. At a market capitalization of $7.5M, SXLXF is classified as a micro-cap stock with approximately 158.6M shares outstanding.
Latest News
Slam Exploration has 6 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all SXLXF news →
SEC Filings
Financial Highlights
Upcoming Events
Stock option expiration
Slam Exploration has 1 upcoming scheduled event. The next event, "Stock option expiration", is scheduled for April 29, 2029 (in 1068 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the SXLXF stock price.
Short Interest History
Short interest in Slam Exploration (SXLXF) currently stands at 4 shares, down 98.3% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 98.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Slam Exploration (SXLXF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
SXLXF Company Profile & Sector Positioning
Slam Exploration (SXLXF) operates in the Gold industry within the broader Basic Materials sector and is listed on the OTC Link.